| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.3 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.3 |